All the results above provide new insights into better understanding biological indicators, such as XPO4, TGFβ1, ANGPTL4 and elF5A2, in the prediction and evaluation of liver cancer, as well as signaling pathways in the control of liver cancer. This evidence concerns the gene XPO4 and liver cancer.